{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:13:00Z","timestamp":1793056380998,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Skin manifestations of hyperandrogenism are common and clinically diverse findings, indicating the complex interplay between metabolic, endocrine, and dermatologic systems. The aim of this review was to collect and analyze data on skin manifestations of hyperandrogenism and review the current treatment options for these diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a narrative review of the current literature focusing on cutaneous manifestations associated with hyperandrogenism. A search was performed on PubMed\/MEDLINE which includes relevant articles published until February 2026. The search strategy included combinations of MeSH keywords (\u201chyperandrogenism,\u201d \u201cpolycystic ovary syndrome,\u201d \u201cskin diseases,\u201d \u201chirsutism,\u201d \u201cacne Vulgaris,\u201d \u201calopecia,\u201d \u201cacanthosis nigricans,\u201d \u201cacrochordons,\u201d and \u201chyperhidrosis\u201d) and screening of reference lists of selected articles. Eligible articles were considered those addressing epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of dermatologic manifestations associated with hyperandrogenism, with an emphasis on more recent bibliographic evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The dermatologic spectrum of hyperandrogenism-induced manifestations primarily includes hirsutism, acne vulgaris, androgenetic alopecia, acanthosis nigricans, acrochordons, and hyperhidrosis. These cutaneous features are often the earliest clinical indicators of hyperandrogenism and are tightly associated with androgen receptor (AR) activation, local enzymatic conversion, and downstream metabolic and inflammatory pathways. Multiple therapeutic strategies were reviewed with an emphasis on hormonal agents which target AR in the skin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hyperandrogenism and the expression of AR in the skin precipitate the development of androgen-associated dermatologic conditions. Androgen-targeted treatment appears to be more effective when compared with other non-androgen-targeted therapeutic options. Further research is required to analyze the existing treatments and develop new approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s42000-026-00785-0","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:24:01Z","timestamp":1777922641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Skin manifestations of hyperandrogenism: an update"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5855-0393","authenticated-orcid":false,"given":"Stefania","family":"Magkou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4763-8394","authenticated-orcid":false,"given":"Evangelia","family":"Sali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5890-5783","authenticated-orcid":false,"given":"Ioanna A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia M.","family":"Dimopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tagka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Chasapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1376","authenticated-orcid":false,"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"3","key":"785_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s1472-6483(10)60347-1","volume":"15","author":"R Palermo","year":"2007","unstructured":"Palermo R (2007) Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online 15(3):326\u2013337. https:\/\/doi.org\/10.1016\/s1472-6483(10)60347-1","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"785_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jaad.2015.05.026","volume":"73","author":"TH Schmidt","year":"2015","unstructured":"Schmidt TH, Shinkai K (2015) Evidence-based approach to cutaneous hyperandrogenism in women. J Am Acad Dermatol 73(4):672\u2013690. https:\/\/doi.org\/10.1016\/j.jaad.2015.05.026","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"785_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ddg.15630","volume":"23","author":"M Chen","year":"2025","unstructured":"Chen M, Nguyen W, Haq Z, Guo W, Briley J (2025) Prevalence of female hirsutism and PCOS in the United States: A cross-sectional study. J Dtsch Dermatol Ges 23(3):330\u2013338. https:\/\/doi.org\/10.1111\/ddg.15630","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"785_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","volume":"12","author":"M Di Lorenzo","year":"2023","unstructured":"Di Lorenzo M, Cacciapuoti N, Lonardo MS, Nasti G, Gautiero C, Belfiore A et al (2023) Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. Curr Nutr Rep 12(3):527\u2013544. https:\/\/doi.org\/10.1007\/s13668-023-00479-8","journal-title":"Curr Nutr Rep"},{"issue":"12","key":"785_CR5","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.3390\/ijms26125575","volume":"26","author":"MA Patni","year":"2025","unstructured":"Patni MA, Dube R, Kar SS, George BT, Kuruba MGB, Srinivasamurthy SK, Elamin AAE (2025) Exploring Hirsutism: Epidemiology, Associated Endocrinal Abnormalities, and Societal Challenges in GCC-A Narrative Review. Int J Mol Sci 26(12):5575. https:\/\/doi.org\/10.3390\/ijms26125575","journal-title":"Int J Mol Sci"},{"issue":"1","key":"785_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43042-019-0031-4","volume":"20","author":"S Ashraf","year":"2019","unstructured":"Ashraf S, Nabi M, Rasool SA, Rashid F, Amin S (2019) Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egypt J Med Hum Genet 20(1):25. https:\/\/doi.org\/10.1186\/s43042-019-0031-4","journal-title":"Egypt J Med Hum Genet"},{"issue":"2","key":"785_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1542\/pir.2022-005617","volume":"45","author":"NR Fraga","year":"2024","unstructured":"Fraga NR, Minaeian N, Kim MS (2024) Congenital Adrenal Hyperplasia. Pediatr Rev 45(2):74\u201384. https:\/\/doi.org\/10.1542\/pir.2022-005617","journal-title":"Pediatr Rev"},{"key":"785_CR8","doi-asserted-by":"publisher","first-page":"1059473","DOI":"10.3389\/fendo.2022.1059473","volume":"13","author":"P Bond","year":"2022","unstructured":"Bond P, Smit DL, de Ronde W (2022) Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne) 13:1059473. https:\/\/doi.org\/10.3389\/fendo.2022.1059473","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"785_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.mcna.2021.06.008","volume":"105","author":"A Sharma","year":"2021","unstructured":"Sharma A, Welt CK (2021) Practical Approach to Hyperandrogenism in Women. Med Clin North Am 105(6):1099\u20131116. https:\/\/doi.org\/10.1016\/j.mcna.2021.06.008","journal-title":"Med Clin North Am"},{"key":"785_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-29223-2","author":"M Stracquadanio","year":"2019","unstructured":"Stracquadanio M (2019) Managing Women\u2019s Hyperandrogenism. Springer. https:\/\/doi.org\/10.1007\/978-3-030-29223-2","journal-title":"Springer"},{"issue":"2","key":"785_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.6065\/apem.2244124.062","volume":"27","author":"HG Lee","year":"2022","unstructured":"Lee HG, Kim CJ (2022) Classic and backdoor pathways of androgen biosynthesis in human sexual development. Ann Pediatr Endocrinol Metab 27(2):83\u201389. https:\/\/doi.org\/10.6065\/apem.2244124.062","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"785_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.mce.2017.09.009","volume":"465","author":"JM Ceruti","year":"2018","unstructured":"Ceruti JM, Leir\u00f3s GJ, Bala\u00f1\u00e1 ME (2018) Androgens and androgen receptor action in skin and hair follicles. Mol Cell Endocrinol 465:122\u2013133. https:\/\/doi.org\/10.1016\/j.mce.2017.09.009","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"785_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.21037\/tp.2017.09.08","volume":"6","author":"M Lause","year":"2017","unstructured":"Lause M, Kamboj A, Fernandez Faith E (2017) Dermatologic manifestations of endocrine disorders. Transl Pediatr 6(4):300\u2013312. https:\/\/doi.org\/10.21037\/tp.2017.09.08","journal-title":"Transl Pediatr"},{"issue":"3","key":"785_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ejendo\/lvaf030","volume":"192","author":"AD Bizuneh","year":"2025","unstructured":"Bizuneh AD, Joham AE, Tay CT, Kiconco S, Earnest A, Dhungana RR et al (2025) The PCOS Phenotype in Unselected Populations study: ethnic variation in population-based normative cut-offs for defining hirsutism. Eur J Endocrinol 192(3):228\u2013239. https:\/\/doi.org\/10.1093\/ejendo\/lvaf030","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"785_CR15","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.3390\/diagnostics12081922","volume":"12","author":"PM Spritzer","year":"2022","unstructured":"Spritzer PM, Marchesan LB, Santos BR, Fighera TM (2022) Hirsutism, Normal Androgens and Diagnosis of PCOS. Diagnostics (Basel) 12(8):1922. https:\/\/doi.org\/10.3390\/diagnostics12081922","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"785_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1210\/jc.2018-00241","volume":"103","author":"KA Martin","year":"2018","unstructured":"Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH (2018) Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 103(4):1233\u20131257. https:\/\/doi.org\/10.1210\/jc.2018-00241","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"785_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1530\/EJE-13-0039","volume":"168","author":"D Panidis","year":"2013","unstructured":"Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA (2013) The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome. Eur J Endocrinol 168(6):871\u2013877. https:\/\/doi.org\/10.1530\/EJE-13-0039","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"785_CR18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jc.2015-4009","volume":"101","author":"R Pasquali","year":"2016","unstructured":"Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM (2016) Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. J Clin Endocrinol Metab 101(5):2013\u20132022. https:\/\/doi.org\/10.1210\/jc.2015-4009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9588","key":"785_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370(9588):685\u2013697. https:\/\/doi.org\/10.1016\/S0140-6736(07)61345-2","journal-title":"Lancet"},{"issue":"6","key":"785_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jaad.2018.08.062","volume":"80","author":"A Bienenfeld","year":"2019","unstructured":"Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR (2019) Androgens in women: Androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol 80(6):1497\u20131506. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.062","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"785_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humupd\/dmr042","volume":"18","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P et al (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 18(2):146\u2013170. https:\/\/doi.org\/10.1093\/humupd\/dmr042","journal-title":"Hum Reprod Update"},{"issue":"3","key":"785_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/ijem.ijem_2_24","volume":"28","author":"VR Khare","year":"2024","unstructured":"Khare VR, Sinha B, Sengupta N, Chatterjee S, Maji D, Majumder A et al (2024) Practise Updates: Diagnosis and Management of Idiopathic Hirsutism. Indian J Endocrinol Metab 28(3):239\u2013249. https:\/\/doi.org\/10.4103\/ijem.ijem_2_24","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"785_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.12998\/wjcc.v11.i2.292","volume":"11","author":"K Unluhizarci","year":"2023","unstructured":"Unluhizarci K, Hacioglu A, Taheri S, Karaca Z, Kelestimur F (2023) Idiopathic hirsutism: Is it really idiopathic or is it misnomer? World J Clin Cases 11(2):292\u2013298. https:\/\/doi.org\/10.12998\/wjcc.v11.i2.292","journal-title":"World J Clin Cases"},{"issue":"2","key":"785_CR24","doi-asserted-by":"publisher","first-page":"e79406","DOI":"10.7759\/cureus.79406","volume":"17","author":"DS Qurtas","year":"2025","unstructured":"Qurtas DS, Ezzat JH (2025) Severity of Hirsutism and Its Correlation With Hyperandrogenism: A Cross-Sectional Study in Erbil City. Cureus 17(2):e79406. https:\/\/doi.org\/10.7759\/cureus.79406","journal-title":"Cureus"},{"issue":"4","key":"785_CR25","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1210\/jc.2017-02052","volume":"103","author":"P Barrionuevo","year":"2018","unstructured":"Barrionuevo P, Nabhan M, Altayar O, Wang Z, Erwin PJ, Asi N, Martin KA, Murad MH (2018) Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. J Clin Endocrinol Metab 103(4):1258\u20131264. https:\/\/doi.org\/10.1210\/jc.2017-02052","journal-title":"J Clin Endocrinol Metab"},{"key":"785_CR26","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.eclinm.2023.102162","volume":"63","author":"S Alesi","year":"2023","unstructured":"Alesi S, Forslund M, Melin J, Romualdi D, Pe\u00f1a A, Tay CT et al (2023) Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine 63:102162. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102162","journal-title":"EClinicalMedicine"},{"issue":"24","key":"785_CR27","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","volume":"326","author":"S Teal","year":"2021","unstructured":"Teal S, Edelman A (2021) Contraception Selection, Effectiveness, and Adverse Effects: A Review. JAMA 326(24):2507\u20132518. https:\/\/doi.org\/10.1001\/jama.2021.21392","journal-title":"JAMA"},{"issue":"3","key":"785_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10815-022-02429-9","volume":"39","author":"ALG Notaro","year":"2022","unstructured":"Notaro ALG, Neto FTL (2022) The use of metformin in women with polycystic ovary syndrome: an updated review. J Assist Reprod Genet 39(3):573\u2013579. https:\/\/doi.org\/10.1007\/s10815-022-02429-9","journal-title":"J Assist Reprod Genet"},{"issue":"8","key":"785_CR29","doi-asserted-by":"publisher","first-page":"CD005552","DOI":"10.1002\/14651858.CD005552.pub3","volume":"8","author":"E Fraison","year":"2020","unstructured":"Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, Costello MF (2020) Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev 8(8):CD005552. https:\/\/doi.org\/10.1002\/14651858.CD005552.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"785_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.soard.2014.02.046","volume":"10","author":"GM Eid","year":"2014","unstructured":"Eid GM, McCloskey C, Titchner R, Korytkowski M, Gross D, Grabowski C, Wilson M (2014) Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass. Surg Obes Relat Dis 10(5):787\u2013791. https:\/\/doi.org\/10.1016\/j.soard.2014.02.046","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"785_CR31","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11695-018-3155-6","volume":"28","author":"JP Chris","year":"2018","unstructured":"Chris JP, Falcone T (2018) Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS). Obes Surg 28(8):2171\u20132177. https:\/\/doi.org\/10.1007\/s11695-018-3155-6","journal-title":"Obes Surg"},{"issue":"8","key":"785_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/oncolo\/oyad099","volume":"28","author":"LM Cordes","year":"2023","unstructured":"Cordes LM, Karzai F, Figg WD, Madan RA (2023) Relugolix in Clinical Practice: The Best Route for All? Oncologist 28(8):647\u2013650. https:\/\/doi.org\/10.1093\/oncolo\/oyad099","journal-title":"Oncologist"},{"issue":"23","key":"785_CR33","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","volume":"382","author":"ND Shore","year":"2020","unstructured":"Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R et al (2020) Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 382(23):2187\u20132196. https:\/\/doi.org\/10.1056\/NEJMoa2004325","journal-title":"N Engl J Med"},{"issue":"2","key":"785_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.xfre.2023.02.007","volume":"4","author":"MC Snabes","year":"2023","unstructured":"Snabes MC, Ng J, Li H, Ali I, Shebley M, Schlaff WD (2023) Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome. F S Rep 4(2):206\u2013212. https:\/\/doi.org\/10.1016\/j.xfre.2023.02.007","journal-title":"F S Rep"},{"issue":"2","key":"785_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/jdv.13447","volume":"30","author":"AC Vissing","year":"2016","unstructured":"Vissing AC, Taudorf EH, Haak CS, Philipsen PA, Haedersdal M (2016) Adjuvant eflornithine to maintain IPL-induced hair reduction in women with facial hirsutism: a randomized controlled trial. J Eur Acad Dermatol Venereol 30(2):314\u2013319. https:\/\/doi.org\/10.1111\/jdv.13447","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"785_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","volume":"57","author":"I Hamzavi","year":"2007","unstructured":"Hamzavi I, Tan E, Shapiro J, Lui H (2007) A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 57(1):54\u201359. https:\/\/doi.org\/10.1016\/j.jaad.2006.09.025","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"785_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.det.2011.09.001","volume":"30","author":"S Knutsen-Larson","year":"2012","unstructured":"Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP (2012) Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin 30(1):99\u2013ix. https:\/\/doi.org\/10.1016\/j.det.2011.09.001","journal-title":"Dermatol Clin"},{"issue":"3","key":"785_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC (2013) Epidemiology of acne vulgaris. Br J Dermatol 168(3):474\u2013485. https:\/\/doi.org\/10.1111\/bjd.12149","journal-title":"Br J Dermatol"},{"issue":"9","key":"785_CR39","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1468-3083.2010.03919.x","volume":"25","author":"AC Perkins","year":"2011","unstructured":"Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB (2011) Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 25(9):1054\u20131060. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03919.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"785_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000347196","volume":"226","author":"MG da Cunha","year":"2013","unstructured":"da Cunha MG, Fonseca FL, Machado CD (2013) Androgenic hormone profile of adult women with acne. Dermatology 226(2):167\u2013171. https:\/\/doi.org\/10.1159\/000347196","journal-title":"Dermatology"},{"issue":"4","key":"785_CR41","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/bjd.17981","volume":"181","author":"RW Clayton","year":"2019","unstructured":"Clayton RW, G\u00f6bel K, Niessen CM, Paus R, van Steensel MAM, Lim X (2019) Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis. Br J Dermatol 181(4):677\u2013690. https:\/\/doi.org\/10.1111\/bjd.17981","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"785_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.18794","volume":"37","author":"C Mias","year":"2023","unstructured":"Mias C, Mengeaud V, Bessou-Touya S, Duplan H (2023) Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway. J Eur Acad Dermatol Venereol 37(Suppl 2):3\u201311. https:\/\/doi.org\/10.1111\/jdv.18794","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"785_CR43","doi-asserted-by":"publisher","first-page":"2298878","DOI":"10.1080\/09546634.2023.2298878","volume":"35","author":"JQ Del Rosso","year":"2024","unstructured":"Del Rosso JQ, Kircik L (2024) The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris. J Dermatol Treat 35(1):2298878. https:\/\/doi.org\/10.1080\/09546634.2023.2298878","journal-title":"J Dermatol Treat"},{"issue":"1","key":"785_CR44","doi-asserted-by":"publisher","first-page":"2296855","DOI":"10.1080\/09546634.2023.2296855","volume":"35","author":"JQ Del Rosso","year":"2024","unstructured":"Del Rosso JQ, Kircik L (2024) The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management. J Dermatol Treat 35(1):2296855. https:\/\/doi.org\/10.1080\/09546634.2023.2296855","journal-title":"J Dermatol Treat"},{"issue":"10","key":"785_CR45","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.3390\/ijms25105302","volume":"25","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Kim YH (2024) Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies. Int J Mol Sci 25(10):5302. https:\/\/doi.org\/10.3390\/ijms25105302","journal-title":"Int J Mol Sci"},{"key":"785_CR46","doi-asserted-by":"publisher","first-page":"1324930","DOI":"10.3389\/fimmu.2023.1324930","volume":"14","author":"Z Jin","year":"2023","unstructured":"Jin Z, Song Y, He L (2023) A review of skin immune processes in acne. Front Immunol 14:1324930. https:\/\/doi.org\/10.3389\/fimmu.2023.1324930","journal-title":"Front Immunol"},{"key":"785_CR47","doi-asserted-by":"publisher","first-page":"1275269","DOI":"10.3389\/fimmu.2024.1275269","volume":"15","author":"L Huang","year":"2024","unstructured":"Huang L, Yang S, Yu X, Fang F, Zhu L, Wang L et al (2024) Association of different cell types and inflammation in early acne vulgaris. Front Immunol 15:1275269. https:\/\/doi.org\/10.3389\/fimmu.2024.1275269","journal-title":"Front Immunol"},{"issue":"2","key":"785_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/microorganisms9020303","volume":"9","author":"C Mayslich","year":"2021","unstructured":"Mayslich C, Grange PA, Dupin N (2021) Cutibacterium acnes as an Opportunistic Pathogen: An Update of Its Virulence-Associated Factors. Microorganisms 9(2):303. https:\/\/doi.org\/10.3390\/microorganisms9020303","journal-title":"Microorganisms"},{"issue":"5","key":"785_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","volume":"311","author":"TX Cong","year":"2019","unstructured":"Cong TX, Hao D, Wen X, Li XH, He G, Jiang X (2019) From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res 311(5):337\u2013349. https:\/\/doi.org\/10.1007\/s00403-019-01908-x","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"785_CR50","doi-asserted-by":"publisher","first-page":"1006e1","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM et al (2024) Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 90(5):1006e1\u20131006e30. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"785_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/09546634.2019.1654075","volume":"32","author":"N Hazarika","year":"2021","unstructured":"Hazarika N (2021) Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatol Treat 32(3):277\u2013285. https:\/\/doi.org\/10.1080\/09546634.2019.1654075","journal-title":"J Dermatol Treat"},{"issue":"1","key":"785_CR52","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.36849\/JDD.7719","volume":"23","author":"LF Eichenfield","year":"2024","unstructured":"Eichenfield LF, Gold LS, Han J, Hebert AA, Mazzetti A, Moro L et al (2024) Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris. J Drugs Dermatol 23(1):1278\u20131283. https:\/\/doi.org\/10.36849\/JDD.7719","journal-title":"J Drugs Dermatol"},{"key":"785_CR53","doi-asserted-by":"publisher","unstructured":"Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789 (2019) Obstet Gynecol 134(4):e106\u2013e114. https:\/\/doi.org\/10.1097\/AOG.0000000000003475","DOI":"10.1097\/AOG.0000000000003475"},{"issue":"5","key":"785_CR54","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson et al (2016) Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 74(5):945\u201373e33. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.037","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"785_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/13625187.2023.2197539","volume":"28","author":"G Grandi","year":"2023","unstructured":"Grandi G, Guariglia G, Facchinetti F (2023) The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review. Eur J Contracept Reprod Health Care 28(3):184\u2013191. https:\/\/doi.org\/10.1080\/13625187.2023.2197539","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"785_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdin.2023.07.005","volume":"13","author":"S Ntshingila","year":"2023","unstructured":"Ntshingila S, Oputu O, Arowolo AT, Khumalo NP (2023) Androgenetic alopecia: An update. JAAD Int 13:150\u2013158. https:\/\/doi.org\/10.1016\/j.jdin.2023.07.005","journal-title":"JAAD Int"},{"issue":"7","key":"785_CR57","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1210\/jc.2018-02548","volume":"104","author":"E Carmina","year":"2019","unstructured":"Carmina E, Azziz R, Bergfeld W, Escobar-Morreale HF, Futterweit W, Huddleston H et al (2019) Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab 104(7):2875\u20132891. https:\/\/doi.org\/10.1210\/jc.2018-02548","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"785_CR58","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1097\/MS9.0000000000003217","volume":"87","author":"M Farhan","year":"2025","unstructured":"Farhan M, Seyfi A, Alnuaimi A, Alamour M, Alwarafi S, Elastal H et al (2025) A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact. Ann Med Surg 87(5):2804\u20132811. https:\/\/doi.org\/10.1097\/MS9.0000000000003217","journal-title":"Ann Med Surg"},{"issue":"1","key":"785_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12016-025-09034-5","volume":"68","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Zhang Y, Deng S, Yang X, Yao X (2025) Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia. Clin Rev Allergy Immunol 68(1):22. https:\/\/doi.org\/10.1007\/s12016-025-09034-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"15","key":"785_CR60","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMcp2412146","volume":"393","author":"EA Olsen","year":"2025","unstructured":"Olsen EA (2025) Hair Loss in Women. N Engl J Med 393(15):1509\u20131520. https:\/\/doi.org\/10.1056\/NEJMcp2412146","journal-title":"N Engl J Med"},{"issue":"2S","key":"785_CR61","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jaad.2023.05.047","volume":"89","author":"LC Sperling","year":"2023","unstructured":"Sperling LC (2023) The role of the scalp biopsy in the evaluation of alopecia. J Am Acad Dermatol 89(2S):S16\u2013S19. https:\/\/doi.org\/10.1016\/j.jaad.2023.05.047","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"785_CR62","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/jocd.16086","volume":"23","author":"A Asilian","year":"2024","unstructured":"Asilian A, Farmani A, Saber M (2024) Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol 23(3):949\u2013957. https:\/\/doi.org\/10.1111\/jocd.16086","journal-title":"J Cosmet Dermatol"},{"key":"785_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jvc2.53","volume":"1","author":"M Dominguez-Santas","year":"2022","unstructured":"Dominguez-Santas M, Diaz-Guimaraens B, Saceda-Corralo D, Hermosa-Gelbard A, Mu\u00f1oz-Moreno Arrones O, Pindado-Ortega C et al (2022) The state-of-the-art in the management of androgenetic alopecia: a review of new therapies and treatment algorithms. J Eur Acad Dermatol Venereol Clin Pract 1:176\u2013185. https:\/\/doi.org\/10.1002\/jvc2.53","journal-title":"J Eur Acad Dermatol Venereol Clin Pract"},{"key":"785_CR64","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.2147\/DDDT.S427612","volume":"17","author":"Y Shen","year":"2023","unstructured":"Shen Y, Zhu Y, Zhang L, Sun J, Xie B, Zhang H, Song X (2023) New Target for Minoxidil in the Treatment of Androgenetic Alopecia. Drug Des Dev Ther 17:2537\u20132547. https:\/\/doi.org\/10.2147\/DDDT.S427612","journal-title":"Drug Des Dev Ther"},{"key":"785_CR65","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/CCID.S385861","volume":"16","author":"M Kaiser","year":"2023","unstructured":"Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ (2023) Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clin Cosmet Investig Dermatol 16:1387\u20131406. https:\/\/doi.org\/10.2147\/CCID.S385861","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"785_CR66","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.5826\/dpc.1501a4698","volume":"15","author":"NM Al Sayed","year":"2025","unstructured":"Al Sayed NM, El Morsy EH, Hussein TM, Hassan EM (2025) Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. Dermatol Pract Concept 15(1):4698. https:\/\/doi.org\/10.5826\/dpc.1501a4698","journal-title":"Dermatol Pract Concept"},{"issue":"8","key":"785_CR67","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jocd.13544","volume":"19","author":"A Das","year":"2020","unstructured":"Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T et al (2020) Acanthosis nigricans: A review. J Cosmet Dermatol 19(8):1857\u20131865. https:\/\/doi.org\/10.1111\/jocd.13544","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"785_CR68","doi-asserted-by":"publisher","first-page":"e231749","DOI":"10.1136\/bcr-2019-231749","volume":"13","author":"B O\u2019Brien","year":"2020","unstructured":"O\u2019Brien B, Dahiya R, Kimble R (2020) Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): an extreme subphenotype of polycystic ovary syndrome. BMJ Case Rep 13(4):e231749. https:\/\/doi.org\/10.1136\/bcr-2019-231749","journal-title":"BMJ Case Rep"},{"issue":"10","key":"785_CR69","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/diagnostics12102519","volume":"12","author":"AM Radu","year":"2022","unstructured":"Radu AM, Carsote M, Dumitrascu MC, Sandru F (2022) Acanthosis Nigricans: Pointer of Endocrine Entities. Diagnostics 12(10):2519. https:\/\/doi.org\/10.3390\/diagnostics12102519","journal-title":"Diagnostics"},{"key":"785_CR70","doi-asserted-by":"publisher","unstructured":"Livadas S, Androulakis I, Angelopoulos N, Lytras A, Papagiannopoulos F, Kassi G (2020) Liraglutide administration improves hormonal\/metabolic profile and reproductive features in women with HAIR-AN syndrome. Endocrinol Diabetes Metab Case Rep 19\u20130150. https:\/\/doi.org\/10.1530\/EDM-19-0150","DOI":"10.1530\/EDM-19-0150"},{"issue":"2","key":"785_CR71","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10103-021-03330-0","volume":"37","author":"JM Jord\u00e3o","year":"2022","unstructured":"Jord\u00e3o JM, Stoliar MFF, Melo SS, de Campos GLM, de Forville Mesquita LA, Skare TL (2022) Low-fluence and low-density CO2 laser: histological analysis of collagen fiber changes in skin and its clinical repercussions in photorejuvenation. Lasers Med Sci 37(2):905\u2013911. https:\/\/doi.org\/10.1007\/s10103-021-03330-0","journal-title":"Lasers Med Sci"},{"issue":"1","key":"785_CR72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10103-024-03986-4","volume":"39","author":"Y Ghane","year":"2024","unstructured":"Ghane Y, Heidari N, Hosseini S, Heidari A, Pishraft-Sabet H, Eghbali S, Goodarzi A (2024) Efficacy and safety of lasers versus topical medications for acanthosis nigricans and pseudo-acanthosis nigricans treatment: a systematic review. Lasers Med Sci 39(1):44. https:\/\/doi.org\/10.1007\/s10103-024-03986-4","journal-title":"Lasers Med Sci"},{"key":"785_CR73","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/CCID.S401479","volume":"16","author":"MF Elmasry","year":"2023","unstructured":"Elmasry MF, Khalil MMF, Badawi A, Zaki NS, Fahim A (2023) Efficacy of Fractional Carbon Dioxide (CO2) Laser versus Q-Switched Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) and Potassium-Titanyl-Phosphate (KTP) Lasers in the Treatment of Acanthosis Nigricans. Clin Cosmet Investig Dermatol 16:705\u2013715. https:\/\/doi.org\/10.2147\/CCID.S401479","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"785_CR74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0019-5154.60345","volume":"55","author":"O El Safoury","year":"2010","unstructured":"El Safoury O, Rashid L, Ibrahim M (2010) A study of androgen and estrogen receptors alpha, beta in skin tags. Indian J Dermatol 55(1):20\u201324. https:\/\/doi.org\/10.4103\/0019-5154.60345","journal-title":"Indian J Dermatol"},{"issue":"2","key":"785_CR75","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/2229-5178.202275","volume":"8","author":"MA Keen","year":"2017","unstructured":"Keen MA, Shah IH, Sheikh G (2017) Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study. Indian Dermatol Online J 8(2):104\u2013110. https:\/\/doi.org\/10.4103\/2229-5178.202275","journal-title":"Indian Dermatol Online J"},{"key":"785_CR76","doi-asserted-by":"publisher","unstructured":"Maazi M, Leung AKC, Lam JM (2025) Primary hyperhidrosis: an updated review. Drugs Context 14. https:\/\/doi.org\/10.7573\/dic.2025-3-2. :2025-3-2","DOI":"10.7573\/dic.2025-3-2"},{"issue":"7\u20138","key":"785_CR77","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1024\/1661-8157\/a004025","volume":"112","author":"J Kr\u00fctzfeldt","year":"2023","unstructured":"Kr\u00fctzfeldt J (2023) Hormonelle Ursachen des vermehrten Schwitzens [Hormonal Causes for Excessive Sweating]. Praxis 112(7\u20138):398\u2013402. https:\/\/doi.org\/10.1024\/1661-8157\/a004025","journal-title":"Praxis"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00785-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-026-00785-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00785-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:24:03Z","timestamp":1777922643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-026-00785-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":77,"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1007\/s42000-026-00785-0","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This review is an original, unpublished work and has not been submitted for publication elsewhere. There is no publication of the same or similar work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of original publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}